Clinical trials indicate that participants with a BMI 30 kg/m or those with overweight and comorbid conditions such as type 2 diabetes or metabolic-associated fatty liver disease (MASLD) may experience the most pronounced benefits
Cancer Risk Reduction Lowers the risk of certain cancers (pancreatic, colorectal, breast)
The active outdoor lifestyle and California food culture contribute, though rates vary significantly by neighborhood, with higher prevalence in some South Bay and East County areas
Phase 3 TRIUMPH-4 data showed 9mg achieved 26.4% weight loss versus 28.7% at 12mg over 68 weeks
Although current treatments have considerably improved survival in both DM and non-DM patients with AMI, the presence of DM still carries a higher risk of in-hospital mortality and major cardiovascular complications, doubling the case fatality rate [4,5,6,7]